This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Alteogen, Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Seung Bum Yoo: Innovator in Fusion Protein Technology
Introduction
Seung Bum Yoo is a notable inventor from South Korea, recognized for his contributions to the field of biopharmaceuticals. His work primarily focuses on enhancing the stability and efficacy of protein and peptide drugs through innovative fusion technologies.
Latest Patents
One of his significant inventions is titled "In Vivo Half Life Increased Fusion Protein Or Peptide Maintained By Sustained In Vivo Release, And Method For Increasing In Vivo Half-Life Using Same." This invention relates to a fusion protein or peptide designed to increase its in vivo half-life by ensuring sustained release within the body. The fusion protein or peptide demonstrates excellent stability by binding a physiologically active protein or peptide to an alpha-1 antitrypsin or its mutant, which has been modified to enhance its release and half-life in the bloodstream.
Career Highlights
Throughout his career, Seung Bum Yoo has focused on developing methods that improve the therapeutic potential of protein and peptide drugs. His innovative approaches have the potential to significantly impact the pharmaceutical industry by providing more effective treatment options.
Collaborations
Seung Bum Yoo has collaborated with notable colleagues, including Hye-Shin Chung and Sang Mee Lee, to advance his research and development efforts in the field of biopharmaceuticals.
Conclusion
Seung Bum Yoo's work in fusion protein technology represents a significant advancement in the development of sustained-release drug formulations. His innovative contributions continue to pave the way for future breakthroughs in biopharmaceutical therapies.